Shuttle Pharmaceuticals Holdings announces special shareholder meeting

• Shuttle Pharmaceuticals Holdings will hold a virtual special shareholder meeting on Sept. 3, 2026.
• Shareholders will vote on share issuances tied to the United Dogecoin acquisition, including conversions of Series B-1 Preferred Stock.
• Ballot also covers share issuances tied to a financing, including conversions of Series B-2 Preferred Stock plus warrant exercises.
• Investors will consider an amendment to raise the 2018 Equity Incentive Plan share pool to 8,800,000.
• Other items include a proposed name change to United Compute Inc. plus authority to adjourn the meeting if needed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shuttle Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-037821), on August 13, 2026, and is solely responsible for the information contained therein.